Cite
MLA Citation
M. Sims et al.. “P1293: COMBINING THE IAP ANTAGONIST, TOLINAPANT, WITH A DNA HYPOMETHYLATING AGENT ENHANCES ANTI-TUMOUR MECHANISMS IN PRECLINICAL MODELS OF T-CELL LYMPHOMA..” HemaSphere, vol. 6, n.d., pp. 1178–1179. http://access.bl.uk/ark:/81055/vdc_100159757346.0x000005